Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
TRI-MG
- Development stage
- Unknown
- Lead developer
- Miotic Pharmaceuticals
- Administration
- Oral
01
Overview
**TRI-MG** is an oral nutraceutical tablet marketed by Miotic Pharmaceutical. It combines magnesium glycinate, magnesium citrate, and magnesium sulfate with vitamin E, levocarnitine, and ubidecarenone to provide magnesium supplementation and nutritional support. The product listing specifies 10-tablet packaging and identifies the magnesium salts as providing elemental magnesium. ([mioticpharma.com](https://mioticpharma.com/main-division.html))
- Brand names
- TRI-MG
- Other names
- Magnesium complex
Beyond the preview
Go deeper on TRI-MG.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TRI-MG.